Attached files
| file | filename |
|---|---|
| 8-K - CDEX INC | m2111038k.htm |
| EX-99.1 - PRESS RELEASE, DATED FEBRUARY 10, 2010 - CDEX INC | ex99_1.htm |
| EX-99.3 - CONSULTING AGREEMENT - CDEX INC | ex99_3.htm |
| EX-99.2 - PRESS RELEASE, DATED FEBRUARY 11, 2010 - CDEX INC | ex99_2.htm |
EXHIBIT
99.4
THE CEO'S
CORNER: What’s New!
February
11, 2010
While the
best thing about 2009 for much of the world’s economy is that it is our rear
view mirror, we did end the year with a great ASHP show [see press release for
December 14, 2009], an upswing in sales [see November 30, 2009 CEO Corner],
placement on the GSA schedule for the future [see press release for November 23,
2009] and recognition of the lifesaving capabilities of our ValiMed™ MVS in
award of the 2009 ASHP Literature Award for Pharmacy Practice Research to Dr.
Jim Stevenson and his current and former staff at the CS Mott Children’s
Hospital of the University of Michigan Health System [see press release for
December 2, 2009]. We are starting the New Year with a bang -- signing a
supplier agreement with McKesson Inc. and continuation of our sales momentum
(more on that in coming months from Greg Firmbach, our new President). Awesome
work by the entire CDEX staff!
With
evidence of a thaw in frozen corporate hospital budgets, it is time to
accelerate our marketing and sales efforts, which I am pleased to report, can be
done thanks to loyal investors stepping forward – they are as much a part of the
CDEX team as our Tucson based staff. Finally, with the upswing in units under
contract and the need to look again at increasing production for 2010, I believe
it is time to bring in a commercialization management team with medical and
public company experience to take us to the next level. To complement our
President Greg Firmbach’s strengths in sales and marketing, we are beginning a
search for a new CEO with outstanding product commercialization and public
company experience. Several candidates have already contacted us and we look
forward to hearing from others who may be interested and qualified.
In
addition, as we expand our revenue base we will bring in additional scientific
support to give us a new look at our product and technology plans, which include
reopening our efforts in explosive detection, an area in which we have received
inquiries from other companies.
Many of
you know that Tim Shriver, our COO, has been the Company’s technical rudder in
moving our technology from ideas to marketable products. I think it is safe to
say that he has been the single most important individual in the Company’s
advancement. While Tim has been a true work horse for the Company since its
inception, with Greg moving up to the position of President, Tim will be able to
step down from the day to day rigor of the COO position. He will continue to
lead Technical Operations and support the Company going forward.
In my
last CEO Corner I noted that the CDEX story for 2009 was pulling through during
turbulent economic times with the support of clients, employees, shareholders,
vendors, and investors. The CDEX story for 2010 is shaping up to be the breakout
year that 2009 should have been and getting back to our 2007 and 2008 trend of
record revenues. Thanks for your interest and support of the Company and stay
tuned for the future.
Malcolm
Philips CEO